AstraZeneca settles antitrust action; Lundbeck opens plant in China; Takeda expands in vaccines

@FiercePharma: Novartis flu vaccines cleared in Italy: Gov't lifts suspension on Agrippal and Fluad. Release | Follow @FiercePharma

> AstraZeneca ($AZN) will pay as much as $11 million to settle antitrust litigation that alleged the company kept copycats of the heart drug Toprol XL from reaching the market. Story

> Novartis ($NVS) reports that its plant in Colorado has gotten an affirmative review by the FDA perhaps putting its problems there behind it. Story

> Denmark-based Lundbeck is opening a manufacturing plant in Tianjin, China to make drugs for the market there.  Item

> Takeda is expanding its efforts in vaccines to take advantage of that growing market. Story

Medical Device News

 @FierceMedDev: Covidien's Q4 dipped over last year; the company blames currency fluctuations and an extra selling week in 2011. More | Follow @FierceMedDev

 @MarkHFierce: CardiAQ Valve Technologies, based in CA, raised $32.5 million, according to a regulatory filing. More | Follow @MarkHFierce

 @DamianFierce: St. Jude has won a legal injunction in its ongoing spat with supplier AorTech. News | Follow @DamianFierce

> GE grabs U-Systems to boost its breast imaging capabilities. Article

> Baxter recalls infusion sets over deadly embolism risk. News

Biotech News

 @FierceBiotech: More from FierceBiotechResearch.com: Harvard's microchip, lined with living cells, mimics disease in preclinical drug test. More | Follow @FierceBiotech

 @JohnCFierce: CVS blocking drugs on formulary based on price, part of the payer backlash. Also adding a few back in after discounts. News (sub. req.) | Follow @JohnCFierce

 @RyanMFierce: Bristol-Myers struck a discovery deal with Chiromics , focused on small molecules in multiple diseases. Release | Follow @RyanMFierce

> Takeda takes aim at becoming next big vaccine developer. Report

> Cardioxyl Pharma reports $28M equity round with lead drug against heart failure. News

> GSK reports letdown in PhIII malaria vaccine study. Article

> Gates Foundation backs $13M venture add for flu drug developer. News

> FDA advisers endorse Novo Nordisk's key diabetes drug. Story

And Finally... Two people were killed in an explosion in Canada at the Neptune Technologies & Bioressources plant where the company makes products such as Omega-3 derived from krill. Story
 

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.